Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease

Published:2006-09 Issue:3 Volume:23 Page:502-511
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Fukuchi Ken-ichiro,Tahara Kazuki,Kim Hong-Duck,Maxwell J. Adam,Lewis Terry L.,Accavitti-Loper Mary Ann,Kim Helen,Ponnazhagan Selvarangan,Lalonde Robert

Publisher

Elsevier BV

Subject

Neurology

Reference58 articles.

1. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy;Bacskai;Nat. Med.,2001

2. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy;Bacskai;J. Neurosci.,2002

3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease;Bard;Nat. Med.,2000

4. Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology;Bard;Proc. Natl. Acad. Sci. U. S. A.,2003

5. Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport;Bayer;Brain Pathol.,2001

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of engineered antibodies (scFvs and nanobodies) targeting pathological protein aggregates in Alzheimer’s disease;Expert Opinion on Investigational Drugs;2024-08-26

2. AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies;npj Parkinson's Disease;2023-06-15

3. Antibodies With Chaperone Function;PROG BIOCHEM BIOPHYS;2023

4. AAV-mediated Expression of a Novel Conformational Anti-Aggregated α-Synuclein Antibody Prolongs Survival in a Genetic Model of α-Synucleinopathies;2022-12-01

5. AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System;Frontiers in Neurology;2022-04-12